Through troubleshooting, the customer replaced the physiological saline in the r1 reagent chamber, which resolved the issue.Return testing was not completed as returns were not available.A review of tickets determined normal complaint activity for lot 07560ui19, and no trends were identified for the product for the complaint issue.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the architect system operations manual provides multiple probable causes and corrective actions for controls being out of range or depressed concentration.The issue was caused by the saline in the r1 reagent chamber and not the creatine kinase reagent.Based on the investigation no product deficiency was identified for the creatine kinase, lot 07560un19.Correction to d suspect medical device, 4.Exp date from 01jan2020 to 02jan2020.
|